Idéal Investisseur Galteron Galteron
Français English
CAC 40 : Market open
8 213,78 pts
-0.04%


Last updated : 18/11/2026 - 09h31
🏠 Home   ➤    Stock news

Patents: Nyxoah Obtains a Default Decision Against Inspire Medical in Munich

The legal dispute between Nyxoah and Inspire Medical Systems has reached a new stage. The Belgian company has made public a favorable decision handed down in Munich by the European patent court, in a press release dated November 18, 2026, issued under inside information disclosure rules.

The specialist in neurostimulation for obstructive sleep apnea said it is currently examining all possible enforcement options.


Patents: Nyxoah Obtains a Default Decision Against Inspire Medical in Munich

A Patent Infringement Action Concerning European Patent 2 760 534

The Court of First Instance of the Unified Patent Court (Juridiction unifiée du brevet), sitting in Munich, Germany, issued a default decision in favor of Nyxoah.

The proceedings were initiated by the company from Mont-Saint-Guibert, which brought a patent infringement action before this court against Inspire Medical Systems. The action concerns European patent 2 760 534, held by Nyxoah.

A Final Outcome Listed by Nyxoah Among Its Uncertainties

In the section devoted to its forward-looking statements, Nyxoah lists "the final outcome of any legal action or judicial proceeding between Nyxoah and Inspire Medical Systems" among the factors subject to risks and uncertainties. The company itself therefore presents the outcome of the dispute as not definitively established.

Listed on Euronext Brussels and on the Nasdaq, Nyxoah markets the Genio system, a hypoglossal nerve neurostimulation therapy that is leadless and batteryless. The device has held CE marking since 2019 and was approved by the FDA in August 2025.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Dispositifs médicaux et optique › Dispositifs médicaux


Context

Period
  • Period: 9M 2026
Key reported figures
  • Revenue: 23,2 millions d'euros
  • Quarterly revenue: 23,2 millions d'euros
  • Revenue growth: 430,6 %
  • Net income: -66,7 millions d'euros
Guidance from the release
  • « The Company expects global net revenue for the full year 2026 to be in the range of €33 million to €35 million. »
Outlook / guidance
  • Expected revenue: 34 millions d'euros
  • Management commentary: « The Company expects global net revenue for the full year 2026 to be in the range of €33 million to €35 million. »

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours